BR9711676A - M-todo de tratamento de doen-asd pÄs-menop usicas incluindo osteoporose - Google Patents

M-todo de tratamento de doen-asd pÄs-menop usicas incluindo osteoporose

Info

Publication number: BR9711676A
Authority: BR; Brazil
Prior art keywords: post; treatment method; method including; including osteoporosis; menopausal disease
Prior art date: 1996-09-06

Application number

BR9711676A

Other languages

English (en)

Inventor

Jeremy N Bradbeer

Jacqueline Beeseley

Richard Bradbeer

Maxine Gowen

Original Assignee

Smithkline Beecha Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-09-06

Filing date

1997-09-03

Publication date

1999-08-24

1997-09-03 Application filed by Smithkline Beecha Corp filed Critical Smithkline Beecha Corp

1999-08-24 Publication of BR9711676A publication Critical patent/BR9711676A/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Vascular Medicine (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pyrrole Compounds (AREA)
Saccharide Compounds (AREA)
Pyridine Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BR9711676A 1996-09-06 1997-09-03 M-todo de tratamento de doen-asd pÄs-menop usicas incluindo osteoporose BR9711676A (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US2543996P	1996-09-06	1996-09-06
US5066697P	1997-06-24	1997-06-24
PCT/US1997/015474 WO1998009519A1 (en)	1996-09-06	1997-09-03	Method of treating post menopausal diseases, including osteoporosis

Publications (1)

Publication Number	Publication Date
BR9711676A true BR9711676A (pt)	1999-08-24

Family

ID=26699738

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
BR9711681A BR9711681A (pt)	1996-09-06	1997-09-03	Novos m-todos
BR9711676A BR9711676A (pt)	1996-09-06	1997-09-03	M-todo de tratamento de doen-asd pÄs-menop usicas incluindo osteoporose

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
BR9711681A BR9711681A (pt)	1996-09-06	1997-09-03	Novos m-todos

Country Status (16)

Country	Link
EP (2)	EP0929216A4 (pt)
JP (2)	JP2002515047A (pt)
KR (2)	KR20000068472A (pt)
CN (2)	CN1236299A (pt)
AR (1)	AR008155A1 (pt)
AU (2)	AU4247397A (pt)
BR (2)	BR9711681A (pt)
CA (2)	CA2264943A1 (pt)
CO (2)	CO5070658A1 (pt)
CZ (1)	CZ76699A3 (pt)
IL (1)	IL128645A0 (pt)
NO (2)	NO991096D0 (pt)
PL (2)	PL332038A1 (pt)
TR (2)	TR199900506T2 (pt)
TW (1)	TW411273B (pt)
WO (2)	WO1998009519A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998034608A1 (en) *	1997-02-11	1998-08-13	Novo Nordisk A/S	Methods for treatment or prophylaxis of menopausal symptoms
GB9827121D0 (en) *	1998-12-09	1999-02-03	Orion Corp	Agent for lowering endothelin levels
DE19905961A1 (de) *	1999-02-12	2000-08-17	Stefan Neubauer	Verwendung von Östrogenen zur Behandlung der Herzinsuffizienz
US6528681B2 (en) *	2000-04-05	2003-03-04	Bristol-Meyers Squibb Pharma Company	Halogenated triphenylethylene derivatives as selective estrogen receptor modulators
IL145876A0 (en)	2000-10-17	2002-07-25	Pfizer Prod Inc	Methods and kits for improving vascular health

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2196003A (en) *	1986-09-11	1988-04-20	Nat Res Dev	Iodo-and bromo-tamoxifen derivatives
DK0660821T3 (da) *	1992-09-15	1998-09-21	Merrell Pharma Inc	Ikke-metaboliserbare clomiphen-analoge til behandling af tamoxifen-resistente tumorer
US5681835A (en) *	1994-04-25	1997-10-28	Glaxo Wellcome Inc.	Non-steroidal ligands for the estrogen receptor
US5604248A (en) *	1994-05-05	1997-02-18	Eli Lilly And Company	Method for minimizing the uterotrophic effect of tamoxifen and tamoxifen analogs
US5470883A (en) *	1994-05-23	1995-11-28	Stromberg; Brent V.	Method of treating peripheral vasoconstriction with tamoxifen citrate
AU6277396A (en) *	1995-06-07	1996-12-30	Neorx Corporation	Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
HN1996000101A (es) *	1996-02-28	1997-06-26	Inc Pfizer	Terapia combinada para la osteoporosis
US6069175A (en) *	1996-11-15	2000-05-30	Pfizer Inc.	Estrogen agonist/antagonists treatment of atherosclerosis

1997
- 1997-08-29 AR ARP970103968A patent/AR008155A1/es unknown
- 1997-09-03 AU AU42473/97A patent/AU4247397A/en not_active Abandoned
- 1997-09-03 BR BR9711681A patent/BR9711681A/pt not_active Application Discontinuation
- 1997-09-03 EP EP97940773A patent/EP0929216A4/en not_active Withdrawn
- 1997-09-03 PL PL97332038A patent/PL332038A1/xx unknown
- 1997-09-03 WO PCT/US1997/015474 patent/WO1998009519A1/en not_active Ceased
- 1997-09-03 WO PCT/US1997/015475 patent/WO1998009619A1/en not_active Ceased
- 1997-09-03 CA CA002264943A patent/CA2264943A1/en not_active Abandoned
- 1997-09-03 PL PL97332278A patent/PL332278A1/xx unknown
- 1997-09-03 KR KR1019997001860A patent/KR20000068472A/ko not_active Withdrawn
- 1997-09-03 TR TR1999/00506T patent/TR199900506T2/xx unknown
- 1997-09-03 CA CA002264775A patent/CA2264775A1/en not_active Abandoned
- 1997-09-03 TR TR1999/00504T patent/TR199900504T2/xx unknown
- 1997-09-03 CZ CZ99766A patent/CZ76699A3/cs unknown
- 1997-09-03 IL IL12864597A patent/IL128645A0/xx unknown
- 1997-09-03 JP JP51283898A patent/JP2002515047A/ja active Pending
- 1997-09-03 JP JP51283798A patent/JP2002515046A/ja active Pending
- 1997-09-03 EP EP97942388A patent/EP0927029A4/en not_active Withdrawn
- 1997-09-03 BR BR9711676A patent/BR9711676A/pt not_active Application Discontinuation
- 1997-09-03 KR KR1019997001861A patent/KR20000068473A/ko not_active Withdrawn
- 1997-09-03 CN CN97199492A patent/CN1236299A/zh active Pending
- 1997-09-03 CN CN97199493A patent/CN1236313A/zh active Pending
- 1997-09-03 AU AU44097/97A patent/AU4409797A/en not_active Abandoned
- 1997-09-04 CO CO97051289A patent/CO5070658A1/es unknown
- 1997-09-04 CO CO97051287A patent/CO4920218A1/es unknown
- 1997-12-11 TW TW086112930A patent/TW411273B/zh active
1999
- 1999-03-05 NO NO991096A patent/NO991096D0/no not_active Application Discontinuation
- 1999-03-05 NO NO991097A patent/NO991097D0/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
AU4409797A (en)	1998-03-26
BR9711681A (pt)	1999-08-24
EP0929216A1 (en)	1999-07-21
CO5070658A1 (es)	2001-08-28
AU4247397A (en)	1998-03-26
WO1998009619A1 (en)	1998-03-12
TR199900504T2 (xx)	1999-06-21
WO1998009519A1 (en)	1998-03-12
CZ76699A3 (cs)	1999-08-11
IL128645A0 (en)	2000-01-31
PL332038A1 (en)	1999-08-16
AR008155A1 (es)	1999-12-09
CN1236299A (zh)	1999-11-24
EP0929216A4 (en)	2001-04-04
NO991097L (no)	1999-03-05
EP0927029A4 (en)	2001-06-13
JP2002515046A (ja)	2002-05-21
NO991096L (no)	1999-03-05
CA2264943A1 (en)	1998-03-12
TW411273B (en)	2000-11-11
CA2264775A1 (en)	1998-03-12
NO991096D0 (no)	1999-03-05
KR20000068473A (ko)	2000-11-25
CN1236313A (zh)	1999-11-24
EP0927029A1 (en)	1999-07-07
KR20000068472A (ko)	2000-11-25
CO4920218A1 (es)	2000-05-29
JP2002515047A (ja)	2002-05-21
TR199900506T2 (xx)	1999-07-21
NO991097D0 (no)	1999-03-05
PL332278A1 (en)	1999-08-30

Publication	Publication Date	Title
IS4812A (is)	1998-07-28	Samsett meðferð fyrir beingisnun
DE59708166D1 (de)	2002-10-17	Röntgenaufnahme-Verfahren
FI952996L (fi)	1995-12-17	Jätteen käsittelymenetelmä
SG50018A1 (en)	1998-06-15	Method for developing treatment
DE69730066D1 (de)	2004-09-09	Röntgenstrahlapparat
NO990531D0 (no)	1999-02-04	Partikkel-siktanordning
DE69724288D1 (de)	2003-09-25	Vorrichtung zum fusionieren von benachbarten knochenstrukturen
FI951702A7 (fi)	1995-10-13	Farmaseuttinen menetelmä osteoporoosin hoitamiseksi
NO950275D0 (no)	1995-01-25	Kombinasjonsbehandling for osteoporose
DE69623437D1 (de)	2002-10-10	Wasserbehandlungsapparat
SG65673A1 (en)	1999-06-22	Developing method
PT883718E (pt)	2002-04-29	Aparelho de dragagem
NO993019D0 (no)	1999-06-18	Elektrolyseapparat
IS4789A (is)	1998-06-30	Meðferðarefnasambönd
GB9605828D0 (en)	1996-05-22	Treatment method
DE69735884D1 (de)	2006-06-22	Modemsteuerverfahren
DE69704054D1 (de)	2001-03-15	Modemsteuerungsverfahren
BR9711676A (pt)	1999-08-24	M-todo de tratamento de doen-asd pÄs-menop usicas incluindo osteoporose
ID16924A (id)	1997-11-20	Metode perlakuan poliolefin
GB9714841D0 (en)	1997-09-17	Treatment method
FI972383A0 (fi)	1997-06-05	Osteoporoosihoitojaksoon tarkoitettu pakkaus
GB9814785D0 (en)	1998-09-09	Waste treatment method
DE69936533D1 (de)	2007-08-23	Neue behandlungsmethode
LV10943A (lv)	1995-12-20	N-benziloksikarbonilarginina 4-metilkumaril-7-amida iegusanas metode
PL313987A1 (en)	1996-10-14	Fluoxetin obtained method

Legal Events

Date	Code	Title	Description
2003-10-21	FA10	Dismissal: dismissal - article 33 of industrial property law
2004-06-08	B11Y	Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]